Drugs / Fluorine dara marina
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT04714827 Background | Jan 2021 → Sep 2024 | plasma cell myeloma | Shanxi Province Cancer Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT04714593 Background | Jan → Dec 2021 | B-cell acute lymphoblastic leukemia | Shanxi Province Cancer Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT04715217 Background | Jan 2021 → Oct 2024 | B-cell non-Hodgkin lymphoma | Shanxi Province Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorine dara marina | “Fluorine dara marina injection” NCT04714827 ↗ |
| Known as | Fluorine dara marina injection | “Fluorine dara marina injection” NCT04714827 ↗ |